The Global Pharmaceutical Logistics Market Will Experience an Increase in Demand for Home Healthcare Products Through 2019
![](/46/pdcnewsitem/03/43/46/o8vsNkE6JusMDe0.jpg)
The Global Pharmaceutical Logistics Market is expected to grow at a CAGR of 9.71% from 2015–2019, according to a new report from research firm Technavio.
Many pharmaceutical logistics companies are now focusing on the expansion of their services and product portfolio to meet the global demand for home healthcare. Patients can easily use portable devices to check their blood pressure, glucose levels and other vital signs at home.
“The growth of the home healthcare segment has been a key factor in initiating several business and supply chain changes and is expected to drive growth in the pharmaceutical logistics sector over the next 10 years,” says Faisal Ghaus, Vice President of Technavio.
The Technavio report also highlights new methods of pharmaceutical delivery. Vendors are changing their transportation mode from air to sea for the delivery of medicines and drugs because of certain advantages, including a 70–80% reduction in cost.
Additionally, more vendors are relying on online services to deliver pharmaceutical products to patients. “Vendors have enhanced the use of online services like e-health records, remote monitoring, e-prescribing and mobile health applications, so as to ensure an effortless and quick delivery of medicines directly to patients,” says Ghaus.
Key Information Covered in the Report include:
• Market segmentation, size and forecast through 2019
• Market Growth Drivers:
• Increased Demand for Home Healthcare Products
• For a full detailed list, view the report.
• Market Challenges:
• Inefficient Product Labeling
• Market Trends:
• New Methods of Pharmaceuticals Delivery
• Key Vendors:
• DB Schenker
• Deutsche Post DHL
• FedEx
• United Parcel Service of America Inc.
• Other Prominent Vendors:
• Agility
• Biocair
• CEVA
• Cold Chain Technologies
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance